VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,907 | -37.9% | 4,418 | -9.0% | 0.03% | -36.2% |
| Q2 2023 | $78,732 | -19.7% | 4,857 | -85.2% | 0.05% | +6.8% |
| Q1 2022 | $98,000 | -38.4% | 32,708 | -5.6% | 0.04% | -26.7% |
| Q4 2021 | $159,000 | -27.7% | 34,653 | -0.9% | 0.06% | -38.1% |
| Q3 2021 | $220,000 | 0.0% | 34,971 | -4.9% | 0.10% | +7.8% |
| Q2 2021 | $220,000 | -22.3% | 36,791 | -17.8% | 0.09% | -25.0% |
| Q1 2021 | $283,000 | +14.1% | 44,755 | +1.8% | 0.12% | +16.5% |
| Q4 2020 | $248,000 | +0.4% | 43,966 | +3.4% | 0.10% | -20.8% |
| Q3 2020 | $247,000 | -29.0% | 42,507 | -12.0% | 0.13% | -21.2% |
| Q2 2020 | $348,000 | +64.2% | 48,320 | +6.9% | 0.16% | +89.7% |
| Q1 2020 | $212,000 | -49.0% | 45,220 | -12.7% | 0.09% | +27.9% |
| Q4 2019 | $416,000 | +88.2% | 51,823 | +61.2% | 0.07% | +51.1% |
| Q3 2019 | $221,000 | -21.6% | 32,151 | -5.3% | 0.04% | -23.7% |
| Q2 2019 | $282,000 | -1.7% | 33,941 | +17.6% | 0.06% | -90.3% |
| Q1 2019 | $287,000 | +16.2% | 28,854 | -10.7% | 0.61% | +1354.8% |
| Q4 2018 | $247,000 | -64.5% | 32,311 | -19.1% | 0.04% | -41.7% |
| Q3 2018 | $696,000 | +5.8% | 39,960 | -42.3% | 0.07% | -87.6% |
| Q2 2018 | $658,000 | – | 69,305 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |